25-hydroxycholesterol has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, C; Jiang, S; Li, B; Lu, L; Sha, Y; Sui, L; Tian, P; Wang, Q; Zhang, L | 1 |
| Clowes, KK; Melnykovych, G | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Cancer of Cervix
| Article | Year |
|---|---|
25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
Topics: Animals; Epithelial Cells; Female; Human Papillomavirus Viruses; Humans; Mice; Papillomavirus Infections; Uterine Cervical Neoplasms | 2023 |
Suppression of glucocorticoid-induced elevation of alkaline phosphatase in C-4-1 cells by inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and reversal of the suppression by mevalonate.
Topics: Alkaline Phosphatase; Cells, Cultured; Dexamethasone; Enzyme Induction; Female; Glucocorticoids; Glucosamine; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Uterine Cervical Neoplasms | 1983 |